AVNS (Avanos Medical, Inc.) Stock Financials & Earnings | Market Cap Arena

AVNS (Avanos Medical, Inc.) Stock Financials & Earnings | Market Cap Arena

AVNSAvanos Medical, Inc.

Mkt Cap$621M

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Revenue (TTM)$701M

Net Income (TTM)-$68M

EPS (TTM)-$1.47

Free Cash Flow (TTM)$43M

Gross Margin49.8%

Op. Margin-8.8%

Net Margin-9.7%

FCF Margin6.1%

P/S Ratio (TTM)0.9x

P/E Ratio (TTM)—

YoY Rev Growth+1.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$159M	$91M	$6M
Q2 23	$169M	$98M	$12M
Q3 23	$171M	$96M	$26M
Q4 23	$173M	$95M	$22M
Q1 24	$166M	$95M	$7M
Q2 24	$172M	$96M	$16M
Q3 24	$170M	$93M	$17M
Q4 24	$180M	$99M	$13M
Q1 25	$168M	$90M	$7M
Q2 25	$175M	$92M	$7M
Q3 25	$178M	$81M	$13M
Q4 25	$181M	$86M	-$89M

Valuation

Quarter	P/S	P/E
Q1 23	0.9x	13.9x
Q2 23	0.9x	—
Q3 23	0.9x	—
Q4 23	0.9x	—
Q1 24	0.9x	—
Q2 24	0.9x	80.7x
Q3 24	0.9x	39.6x
Q4 24	0.9x	—
Q1 25	0.9x	—
Q2 25	0.9x	—
Q3 25	0.9x	—
Q4 25	0.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$7M	-$11M
Q2 23	-$3M	-$7M
Q3 23	$29M	$25M
Q4 23	$13M	$7M
Q1 24	-$8M	-$12M
Q2 24	$28M	$22M
Q3 24	$23M	$20M
Q4 24	$58M	$53M
Q1 25	$26M	$19M
Q2 25	$7M	-$4M
Q3 25	$14M	$7M
Q4 25	$28M	$21M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$4M
Q2 23	$4M
Q3 23	$4M
Q4 23	$6M
Q1 24	$4M
Q2 24	$6M
Q3 24	$3M
Q4 24	$5M
Q1 25	$7M
Q2 25	$11M
Q3 25	$7M
Q4 25	$7M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-19.3%	-16.5%
Q2 23	-0.9%	-0.9%
Q3 23	-0.6%	-7.3%
Q4 23	-4.6%	-8.0%
Q1 24	+4.3%	+3.2%
Q2 24	+1.4%	-1.3%
Q3 24	-0.5%	+5.4%
Q4 24	+3.6%	+10.6%
Q1 25	+0.8%	+0.9%
Q2 25	+1.9%	+7.8%
Q3 25	+4.3%	+7.2%
Q4 25	+0.7%	+61.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	2.5%
Q2 23	$4M	2.3%
Q3 23	$4M	2.3%
Q4 23	$4M	2.3%
Q1 24	$4M	2.2%
Q2 24	$4M	2.2%
Q3 24	$3M	1.5%
Q4 24	$4M	2.1%
Q1 25	$4M	2.3%
Q2 25	$4M	2.3%
Q3 25	$4M	2.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$8M	$78M
Q2 23	$7M	$79M
Q3 23	$6M	$64M
Q4 23	$7M	$66M
Q1 24	$7M	$80M
Q2 24	$6M	$73M
Q3 24	$7M	$69M
Q4 24	$6M	$81M
Q1 25	$5M	$77M
Q2 25	$6M	$79M
Q3 25	$6M	$62M
Q4 25	$6M	$78M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$96M	$0	$96M
Q2 23	$82M	$0	$82M
Q3 23	$107M	$0	$107M
Q4 23	$88M	$0	$88M
Q1 24	$76M	$0	$76M
Q2 24	$92M	$0	$92M
Q3 24	$89M	$0	$89M
Q4 24	$108M	$0	$108M
Q1 25	$97M	$0	$97M
Q2 25	$90M	$0	$90M
Q3 25	$71M	$0	$71M
Q4 25	$90M	$0	$90M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	47M	-0.9%
Q2 23	47M	+0.4%
Q3 23	47M	+0.0%
Q4 23	47M	-0.4%
Q1 24	46M	-0.9%
Q2 24	46M	+0.2%
Q3 24	47M	+0.6%
Q4 24	46M	-1.3%
Q1 25	47M	+1.7%
Q2 25	47M	+0.0%
Q3 25	46M	-0.9%
Q4 25	46M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$139K	12K
FY 15	$131K	12K
FY 16	$47K	12K
FY 17	$47K	13K
FY 18	$139K	5K
FY 19	$148K	5K
FY 20	$135K	5K
FY 21	$165K	5K
FY 22	$171K	4K
FY 23	$182K	4K
FY 24	$313K	2K
FY 25	$319K	2K